Zealand Pharma A/S
14
5
6
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
7.1%
1 terminated/withdrawn out of 14 trials
36%
5 trials in Phase 3/4
0%
0 of 7 completed trials have results
Key Signals
Enrollment reporting
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS
Role: lead
Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS
Role: lead
Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS - Extension Trial
Role: lead
A Single and Multiple Ascending Dose Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP6590 in Participants With Normal Weight, Overweight and Obesity
Role: lead
Extension Trial Evaluating the Long-term Safety and Efficacy of Dasiglucagon in Children With Congenital Hyperinsulinism
Role: lead
Efficacy and Safety Evaluation of Glepaglutide in Treatment of Short Bowel Syndrome
Role: lead
A Trial to Understand How Safe and Well Tolerated ZP9830 is and How it Works in People With Plaque Psoriasis Over an 8-week Treatment Period
Role: lead
Pharmacokinetics of Petrelintide in Participants With Impaired Hepatic Function
Role: lead
Investigating the Pharmacokinetics of Petrelintide Using Different Drug Product Concentrations
Role: lead
Once-weekly Petrelintide Versus Placebo for Obesity or Overweight With Co-morbidities
Role: lead
A Research Study Looking at the Safety of Single and Multiple Doses of ZP9830 and How it Works in the Body of Healthy Participants
Role: lead
Pharmacokinetics of Petrelintide Following Administration to Participants With Impaired Renal Function
Role: lead
A Trial Comparing Pharmacokinetics, Safety and Tolerability of Two Subcutaneous Concentrations of Dapiglutide
Role: lead
A Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP7570
Role: lead
All 14 trials loaded